이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Amrutanjan Health Care 관리

관리 기준 확인 2/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Sambhu Sivalenka

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	25.7yrs
CEO 소유권	13.9%
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	3.3yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

Sambhu Sivalenka 의 보수는 Amrutanjan Health Care 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Jun 30 2024	n/a	n/a	₹426m
Mar 31 2024	n/a	n/a	₹450m
Dec 31 2023	n/a	n/a	₹440m
Sep 30 2023	n/a	n/a	₹373m
Jun 30 2023	n/a	n/a	₹432m
Mar 31 2023	n/a	n/a	₹398m
Dec 31 2022	n/a	n/a	₹418m
Sep 30 2022	n/a	n/a	₹517m
Jun 30 2022	n/a	n/a	₹588m
Mar 31 2022	n/a	n/a	₹672m
Dec 31 2021	n/a	n/a	₹627m
Sep 30 2021	n/a	n/a	₹631m
Jun 30 2021	n/a	n/a	₹668m
Mar 31 2021	n/a	n/a	₹612m
Dec 31 2020	n/a	n/a	₹589m
Sep 30 2020	n/a	n/a	₹474m
Jun 30 2020	n/a	n/a	₹322m
Mar 31 2020	₹13m	₹11m	₹251m
Dec 31 2019	n/a	n/a	₹314m
Sep 30 2019	n/a	n/a	₹274m
Jun 30 2019	n/a	n/a	₹257m
Mar 31 2019	₹13m	₹11m	₹250m
Dec 31 2018	n/a	n/a	₹158m
Sep 30 2018	n/a	n/a	₹168m
Jun 30 2018	n/a	n/a	₹201m
Mar 31 2018	₹13m	₹11m	₹200m

보상 대 시장: Indian 시장에서 비슷한 규모의 회사에 비해 Sambhu 의 총 보상이 합리적인지 여부를 입증하기에는 데이터가 부족합니다.

보상과 수익: Sambhu 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Sambhu Sivalenka (50 yo)

25.7yrs

테뉴어

₹12,759,000

보상

Mr. Sambhu Prasad Sivalenka, B.Tech (USA), M.B.A. (USA) has been the Managing Director of Amrutanjan Health Care Limited and serves as its Executive Chairman since February 13, 2012. He has been Director...

이사회 구성원

이름	위치	테뉴어	보상	소유권
Sambhu Sivalenka	Executive Chairman & MD	25.7yrs	₹12.76m	13.94% ₹ 3.3b
V. Nagaraj	Non-Executive Independent Director	less than a year	데이터 없음	데이터 없음
Raja Venkataraman	Independent Non-Executive Director	3.3yrs	₹1.95m	데이터 없음
Ramaa Arikirevula	Non-Executive Non Independent Director	1.3yrs	₹1.12m	3.02% ₹ 711.9m
Govindan Raghavan	Non-Executive & Non Independent Director	9.3yrs	₹1.50m	0.12% ₹ 29.0m
Muralidharan Swayambunathan	Non-Executive Independent Director	3.3yrs	₹2.07m	데이터 없음
Meenalochani Raghunathan	Additional Non-Executive Independent Director	2.1yrs	₹1.49m	데이터 없음

3.3yrs

평균 재임 기간

65yo

평균 연령

경험이 풍부한 이사회: 590006 의 이사회는 경험(평균 재직 기간 3 년)으로 간주됩니다.

Amrutanjan Health Care 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

Amrutanjan Health Care Limited, Annual General Meeting, Sep 23, 2024

Amrutanjan Health Care Limited, Annual General Meeting, Sep 21, 2023

Amrutanjan Health Care Limited Announces Board Changes

Amrutanjan Health Care Limited Appoints Meenalochani Raghunathan as an Additional Director

Non-Executive Independent Director recently bought ₹1.6m worth of stock

Non-Executive Independent Director recently bought ₹549k worth of stock

Recent updates

Amrutanjan Health Care Limited Approves Final Dividend for the Year Ended March 31, 2024

Upcoming dividend of ₹2.60 per share

Dividend of ₹2.60 announced

Amrutanjan Health Care Limited, Annual General Meeting, Sep 23, 2024

First quarter 2025 earnings released: EPS: ₹1.60 (vs ₹2.40 in 1Q 2024)

Amrutanjan Health Care Limited to Report Q1, 2025 Results on Aug 13, 2024

New major risk - Earnings quality

Full year 2024 earnings released: EPS: ₹15.50 (vs ₹13.65 in FY 2023)

Amrutanjan Health Care Limited Recommends Final Dividend for the Financial Year 2023-24

Amrutanjan Health Care Limited to Report Q4, 2024 Results on May 23, 2024

Upcoming dividend of ₹1.00 per share at 0.7% yield

Dividend of ₹1.00 announced

Upcoming dividend of ₹1.00 per share at 0.8% yield

Amrutanjan Health Care Limited Declares First Interim Dividend for the Financial Year 2023-2024

Amrutanjan Health Care Limited Declares Final Dividend for the Year Ended March 31, 2023

Upcoming dividend of ₹2.60 per share at 0.7% yield

Amrutanjan Health Care Limited, Annual General Meeting, Sep 21, 2023

First quarter 2024 earnings released: EPS: ₹2.40 (vs ₹1.26 in 1Q 2023)

Amrutanjan Health Care Limited to Report Q1, 2024 Results on Aug 02, 2023

Amrutanjan Health Care Limited (BSE:590006) announces an Equity Buyback for 320,000 shares, representing 1.09% for INR 288 million.

Amrutanjan Health Care Limited Announces Board Changes

Investor sentiment improves as stock rises 17%

Full year 2023 earnings released: EPS: ₹13.65 (vs ₹23.00 in FY 2022)

Amrutanjan Health Care Limited to Report Q4, 2023 Results on May 27, 2023

Upcoming dividend of ₹1.00 per share at 0.7% yield

Amrutanjan Health Care Limited Declares Interim Dividend for the Financial Year 2022-23

Third quarter 2023 earnings released: EPS: ₹3.67 (vs ₹7.05 in 3Q 2022)

Amrutanjan Health Care Limited to Report Q3, 2023 Results on Feb 14, 2023

Amrutanjan Health Care Limited Declares First Interim Dividend for the Financial Year 2022-23

Second quarter 2023 earnings released: EPS: ₹4.37 (vs ₹6.79 in 2Q 2022)

Amrutanjan Health Care Limited Announces the Launch of Comfy Period Pain Roll-On

Amrutanjan Health Care Limited to Report Q2, 2023 Results on Nov 04, 2022

Amrutanjan Health Care Limited Approves Final Dividend for the Year Ended March 31, 2022

Upcoming dividend of ₹2.60 per share

First quarter 2023 earnings released: EPS: ₹1.26 (vs ₹4.12 in 1Q 2022)

Amrutanjan Health Care Limited Appoints Meenalochani Raghunathan as an Additional Director

Full year 2022 earnings released: EPS: ₹23.05 (vs ₹20.94 in FY 2021)

Amrutanjan Health Care Limited Recommends Final Dividend for the Financial Year 2021-22

Non-Executive Independent Director recently bought ₹1.6m worth of stock

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Amrutanjan Health Care Limited Declares Second Interim Dividend for the Financial Year 2021-22

Amrutanjan Health Care Limited to Report Q3, 2022 Results on Feb 11, 2022

Second quarter 2022 earnings released: EPS ₹6.79 (vs ₹8.06 in 2Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Upcoming dividend of ₹2.60 per share

First quarter 2022 earnings released: EPS ₹4.12 (vs ₹2.20 in 1Q 2021)

Full year 2021 earnings released: EPS ₹20.94 (vs ₹8.58 in FY 2020)

Amrutanjan Health Care Limited Recommends Final Dividend for the Financial Year 2020-21

Non-Executive Independent Director recently bought ₹549k worth of stock

Non-Executive Independent Director recently bought ₹72k worth of stock

Third quarter 2021 earnings released: EPS ₹7.18 (vs ₹3.25 in 3Q 2020)

New 90-day high: ₹586

Amrutanjan Health Care Limited to Report Q3, 2021 Results on Feb 11, 2021

New 90-day high: ₹564

Amrutanjan Health Care Limited Announces Resignation of V. Swaminathan as Non-Executive Independent Director

New 90-day high: ₹518

Market bids up stock over the past week

New 90-day high: ₹487

Amrutanjan Health Care Limited to Report Q2, 2021 Results on Nov 12, 2020

Amrutanjan Health Care Limited Announces Partnership with Chennai Super Kings as Official Pain Relief Partner-Digital for the 2020 Edition of IPL

Amrutanjan Health Care Limited to Report Q1, 2021 Results on Aug 13, 2020

Earnings released

New 90-day high - ₹451

CEO 보상 분석

CEO

테뉴어

보상

이사회 구성원